Cytosorbents Corporation
CTSO
$0.59
$0.000.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.08% | -26.15% | -11.94% | 253.27% | -42.31% |
| Total Receivables | 1.66% | -4.08% | 0.95% | 4.79% | 10.36% |
| Inventory | 31.96% | 7.87% | 22.91% | 10.45% | -15.85% |
| Prepaid Expenses | -33.82% | 76.54% | -57.60% | -4.11% | 217.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -3.19% | -7.28% | -9.55% | 17.63% | 30.16% |
|
|
|||||
| Total Current Assets | -3.19% | -7.28% | -9.55% | 17.63% | 30.16% |
| Net Property, Plant & Equipment | -2.70% | -2.14% | -2.00% | -2.06% | -1.95% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -10.19% | -3.93% | 0.93% | -0.44% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.13% | 0.13% | 0.14% | 2.53% | -85.09% |
| Total Assets | -3.43% | -4.67% | -5.50% | 7.20% | -0.90% |
|
|
|||||
| Total Accounts Payable | -5.47% | -10.58% | 2.06% | -0.44% | 42.85% |
| Total Accrued Expenses | -17.69% | 33.49% | 3.59% | -5.66% | -2.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.44% | 4.65% | 4.45% | 4.61% | 4.86% |
| Total Finance Division Other Current Liabilities | 202.44% | -69.61% | -9.63% | 13.01% | 57.35% |
| Total Other Current Liabilities | 202.44% | -69.61% | -9.63% | 13.01% | 57.35% |
| Total Current Liabilities | -3.99% | 2.74% | 1.09% | -0.90% | 16.55% |
|
|
|||||
| Total Current Liabilities | -3.99% | 2.74% | 1.09% | -0.90% | 16.55% |
| Long-Term Debt | 14.42% | 1.32% | 1.34% | 1.36% | 1.38% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.23% | -1.10% | -1.06% | -1.03% | -0.99% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.22% | 0.90% | 0.46% | -0.07% | 4.20% |
|
|
|||||
| Common Stock & APIC | 0.47% | 0.15% | 0.18% | 2.46% | 0.77% |
| Retained Earnings | -1.79% | -1.04% | 0.64% | -0.49% | -2.94% |
| Treasury Stock & Other | 22.55% | 2.93% | -361.27% | -64.35% | 2,810.01% |
| Total Common Equity | -34.56% | -22.15% | -20.33% | 30.93% | -14.56% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -34.56% | -22.15% | -20.33% | 30.93% | -14.56% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -34.56% | -22.15% | -20.33% | 30.93% | -14.56% |
|
|
|||||